Colchicine’s promise in post-ablation atrial fibrillation: a meta-analysis
Archives of Medical Science – Atherosclerotic Diseases · 09.07.2026 · 11 (1) · 159-166
DOI: 10.5114/amsad/222183 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Archives of Medical Science – Atherosclerotic Diseases, online erschienen am 09.07.2026. Verfasst von Muhammad Irtaza Hussain Bakhtiari und 13 weiteren Autor:innen. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Introduction
Catheter ablation for restoration of sinus rhythm is limited by the high rates of arrhythmia due to inflammation caused by the procedure. Colchicine, a microtubule polymerisation inhibitor, reduces inflammation and may decrease atrial arrhythmia recurrence. We conducted a meta-analysis of RCTs and observational studies to assess the efficacy of colchicine in reducing atrial fibrillation (A fib) recurrence and pericarditis.
Methods
We identified seven studies through the systematic search of the PubMed, Embase, and Cochrane databases from inception to March 2024. Eligible articles had to be RCTs or observational studies comparing the effectiveness of colchicine with placebo in patients who underwent catheter ablation. Outcomes included A fib recurrence, atrial tachycardia, need to perform cardioversion or re-ablation, gastrointestinal (GI) adverse effects, pericarditis, and repeat hospitalisation. A random effects model was used to analyse binary outcomes, and the Mantel-Haenszel method was used to calculate the odds ratio with a 95% confidence interval.
Results
Data from 2165 patients were analysed. Colchicine reduced A fib OR = 0.61 (p = 0.001), pericarditis OR = 0.54 (p = 0.07), and the need for re-ablation OR = 0.53 (p = 0.36). However, it increased GI adverse effects OR = 3.15 (p = 0.008). There was no statistical difference in the need for cardioversion, repeat hospitalisation, and atrial tachycardia between the two groups.
Conclusions
Although colchicine significantly reduced the recurrence of A fib, further investigation is needed for a comprehensive understanding of the efficacy of colchicine in patients with catheter ablation.
Zitieren
APA
Bakhtiari, M. I. H., Adnan, M., Naveed, H., Hamza, M., Khalid, B., Nazar, G., Khalid, M. U., Tufail, Z., Basit, J., Asif, A., Basit, J., Fatima, A., Alam, M., & Alraies, M. C. (2026). Colchicine’s promise in post-ablation atrial fibrillation: a meta-analysis. Archives of Medical Science – Atherosclerotic Diseases, 11(1), 159-166. https://doi.org/10.5114/amsad/222183
Vancouver
Bakhtiari MIH, Adnan M, Naveed H, Hamza M, Khalid B, Nazar G, et al. Colchicine’s promise in post-ablation atrial fibrillation: a meta-analysis. Archives of Medical Science – Atherosclerotic Diseases. 2026;11(1):159-166. doi:10.5114/amsad/222183
BibTeX
@article{Bakhtiari2026,
author = {Bakhtiari, Muhammad Irtaza Hussain and Adnan, Maryam and Naveed, Hamza and Hamza, Mohammad and Khalid, Burhan and Nazar, Gulfam and Khalid, Muhammad Usman and Tufail, Zarnab and Basit, Jawad and Asif, Aneesa and Basit, Jawad and Fatima, Areeb and Alam, Mahboob and Alraies, M Chadi},
title = {Colchicine’s promise in post-ablation atrial fibrillation: a meta-analysis},
journal = {Archives of Medical Science – Atherosclerotic Diseases},
year = {2026},
volume = {11},
number = {1},
pages = {159--166},
doi = {10.5114/amsad/222183}
}
EUVIMED